A robot that costs less than a second-hand car stood on the CCTV Spring Festival Gala stage in February. Nine months later, the company behind it has reportedly walked into Hong Kong's listing queue — and the question is whether a RMB 6 billion (≈US$830M) price tag can rest on a machine that sells for four figures.
Songyan Dynamics (松延动力, also styled Noetix Robotics), the Beijing humanoid (人形机器人) maker founded in 2023 by Tsinghua dropout Jiang Zheyuan (姜哲源), was reported by Bloomberg on 31 October to have made a confidential submission for a Hong Kong initial public offering (首次公开募股). The filing, if it proceeds, would target a raise of several hundred million US dollars and a possible 2027 listing, with details still unsettled.
The B round that set the mark
The listing talk follows a financing that already reset the company's worth. In March 2026 Songyan closed a B round of roughly RMB 1 billion (≈US$139M), led by Chendao Capital (晨道资本) — an industrial-investment platform with ties to CATL (宁德时代) — and joined by Guoke Investment (国科投资), Jingguosheng Fund (京国盛基金) and Jiuhe Venture (九合创投). That round left the company with a post-money valuation around RMB 6 billion (≈US$830M), according to reports — the company's roughly 10th financing round since inception.
Earlier rounds set the stage: an A round of about RMB 360 million (≈US$50M) backed by Sequoia China (红杉中国) and a Beijing advanced-manufacturing fund, with eight rounds before that, leaving cumulative external funding above RMB 1.3 billion (≈US$180M) before the B close. The CATL connection runs deeper than Chendao — industrial investors are betting that a sub-¥10k humanoid can become a volume product rather than a showcase.
The valuation sits on thin revenue. Songyan's 2025 sales "broke RMB 100 million" (≈US$13.9M), the company has said, which at a RMB 6 billion (≈US$830M) post-money implies a price-to-sales multiple near 60 times — a number one analyst cited as baking in heavy delivery expectations. For context, UBTECH (优必选, 09880.HK) traded around 19 times 2025 sales and Dobi (越疆, 02432.HK) around 20 times, while warehouse-robot maker Geek+ (极智嘉, 02590.HK) sat near 3.3 times.
The product that justifies the story
Songyan's headline machine is "Xiaobumi" (小布米), a bipedal humanoid 94 cm tall, 17 kg, with 21 movable joints, priced at RMB 9,998 (≈US$1,389) — the first bipedal humanoid the company says it pushed below the RMB 10,000 line. After the Spring Festival Gala appearance, Xiaobumi topped JD.com's humanoid-robot sales category, and offline orders multiplied. Jiang has publicly targeted at least 10,000 units.
Songyan is not alone in racing for the exit. A wave of robotics and embodied-AI names has lined up for Hong Kong listings in 2026, betting that public capital can fund the leap from prototype to volume. The timing reflects a sector-wide belief that 2026 is the "IPO year" for humanoids — and that the first credible filers will set the valuation yardstick everyone else is measured against.
Delivery, not demos, is the test. By September 2026 Songyan said it had cumulatively delivered more than 5,000 units, roughly 2,000 of them to business customers — meaning the 10,000-unit goal requires the final quarter to more than double the run rate. The company points to three production bases: Beijing (Changping, about 3,000 sq m), Changzhou (Tianning, about 2,100 sq m) and a Dongguan site for bionic humanoids, and says it expects positive operating cash flow in the fourth quarter of 2026.
The 18C question
Hong Kong's Chapter 18C specialist-technology route is the likely path. It splits issuers into "commercialised" — revenue of at least HK$250 million (≈US$32M) in the latest fiscal year, with a temporarily lowered HK$4 billion (≈US$513M) market-cap threshold — and "uncommercialised," with an HK$8 billion (≈US$1.03B) threshold, both relaxed through 31 August 2027. Songyan's RMB 100 million-plus (≈US$13.9M) 2025 sales fall short of the commercialised revenue line, which could push it toward the higher uncommercialised bar — above its latest public valuation.
According to Li An, chief scientist at BrainNet (脑机网), a sub-¥10k humanoid forces the market to price a consumer story and an industrial story at once, and the two rarely arrive on the same schedule.
The founder is candid about the harder problem: generalisation. Today's robots handle trained scenarios but stall in unseen ones, he has said, a gap rooted in the scale and diversity of real-world data. That is the constraint a raise of several hundred million US dollars is meant to help overcome.
Honest limitations
The confidential filing, raise size and 2027 timing are Bloomberg-sourced and unconfirmed by the exchange; the company has not published a prospectus. The B-round size, lead investor and RMB 6 billion (≈US$830M) post-money are from Chinese financial press and a Phoenix Weekly report, not a filing. The ~5,000-unit delivery and 10,000-unit target are the company's own statements. The 18C thresholds are the publicly announced relaxed levels effective through August 2027. Comparable price-to-sales figures for UBTECH, Dobi and Geek+ are calculated from their reported 2025 revenue and market values at the time and are magnitude references only. Nothing here is a recommendation to buy, sell or subscribe.
What readers can do now
- Treat the "secret filing" as a signal, not a certainty. A confidential submission starts a process; it does not commit to a price, size or even a listing.
- Watch the delivery-to-order ratio. If undelivered orders far exceed the ~5,000 units already shipped, the 10,000-unit target is where expectations get tested first.
- Read any future prospectus for the 18C classification. Whether Songyan files as commercialised or uncommercialised tells you which valuation framework the market will apply.
